Spyre Therapeutics Inc (SYRE.O)

+ 收藏

资产负债表(Spyre Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 123112311231123112311231
原始币种 美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见45,144,000.00227,552,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见9,741,000.002,632,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见380,851,000.00257,089,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见435,736,000.00487,273,000.00
非流动资产:
 受限制存款及现金非流动(元) ----321,000.00319,000.00
 非流动资产其他项目(元) -会员可见会员可见会员可见10,000.0010,000.00
 非流动资产合计(元) -会员可见会员可见会员可见331,000.00329,000.00
总资产(元) 会员可见会员可见会员可见会员可见436,067,000.00487,602,000.00
流动负债:
 应付账款及票据(元) 会员可见会员可见会员可见会员可见3,231,000.003,106,000.00
 应付关联方款项流动(元) 会员可见会员可见会员可见会员可见10,568,000.0015,528,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见5,683,000.0021,594,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见会员可见2,640,000.002,590,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见22,122,000.0042,818,000.00
非流动负债:
 非流动负债其他项目(元) -会员可见会员可见会员可见39,560,000.0039,110,000.00
 非流动负债合计(元) -会员可见会员可见会员可见39,560,000.0039,110,000.00
总负债(元) 会员可见会员可见会员可见会员可见61,682,000.0081,928,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见12,000.0010,000.00
 优先股(元) 会员可见会员可见会员可见会员可见155,820,000.00438,332,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见1,066,214,000.00775,966,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-847,108,000.00-808,271,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见-553,000.00-363,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见374,385,000.00405,674,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见374,385,000.00405,674,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见436,067,000.00487,602,000.00
公告日期 2025-08-052025-05-082025-02-272024-11-072024-08-072024-05-09
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院